Arama

EISSN 2148-4279

EJR IS INDEXED IN WEB OF SCIENCE AND PUBMED CENTRAL

European Journal of Rheumatology

PDF

HIGHLY CITED ARTICLES

Coronavirus Disease-2019: Implication for the care and management of patients with systemic lupus erythematosus

Sawalha, Amr H.; Manzi, Susan.

Pediatric macrophage activation syndrome, recognizing the tip of the Iceberg

Crayne, Courtney; Cron, Randy Q.

The emerging role of lung ultrasound in COVID-19 pneumonia

Lepri, Gemma; Orlandi, Martina; Lazzeri, Chiara; Bruni, Cosimo; Hughes, Michael; Bonizzoli, Manuela; Wang, Yukai; Peris, Adriano; Matucci-Cerinic, Marco.

Baricitinib in therapy of COPA syndrome in a 15-year-old girl

Krutzke, Sophia; Rietschel, Christoph; Horneff, Gerd.

New perspectives in the imaging of Raynaud's phenomenon

Herrick, Ariane L.; Dinsdale, Graham; Murray, Andrea.

The contribution of mesenchymal transitions to the pathogenesis of systemic sclerosis

Rosa, Irene; Romano, Eloisa; Fioretto, Bianca Saveria; Manetti, Mirko.

Pediatric Behcet's disease - clinical aspects and current concepts

Yildiz, Mehmet; Koker, Oya; Adrovic, Amra; Sahin, Sezgin; Barut, Kenan; Kasapcopur, Ozgur.

Understanding the cytokine storm during COVID-19: Contribution of preexisting chronic inflammation

Miossec, Pierre.

The impact of COVID-19 on rheumatology clinical practice and university teaching in Sydney, Australia

Cai, Ken; He, Jianna; Wong, Peter K. K.; Manolios, Nicholas.

Characteristics of coexisting localized scleroderma and inflammatory arthritis

Reiff, Daniel; Crayne, Courtney B.; Mannion, Melissa L.; Cron, Randy Q.

All Title Keyword Full Text DOI

Authors

Article Type

Article Category

Year

Search Results

Total of 2 results

Ranking

Release Date Sort Sort Article Type

The burning question: To use or not to use cyclophosphamide in systemic sclerosis

Cosimo Bruni, Daniel E. Furst

(Eur J Rheumatol 2020; 7: S237-S241) DOI: 10.5152/eurjrheum.2020.19104

Abstract Full Text (PDF) Related Articles

Long-term safety and efficacy of olokizumab in patients with rheumatoid arthritis and inadequate response to tumor necrosis factor inhibitor therapy in phase II studies

Mark C. Genovese, Patrick Durez, Roy Fleischmann, Yoshiya Tanaka, Daniel Furst, Hisashi Yamanaka, Elena Korneva, Igor Vasyutin, Tsutomu Takeuchi

(Eur J Rheumatol 2021; 8: 120-129) DOI: 10.5152/eurjrheum.2021.19207

Abstract Full Text (PDF) Related Articles